These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28216048)

  • 21. Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue.
    Takanari H; Nalos L; Stary-Weinzinger A; de Git KC; Varkevisser R; Linder T; Houtman MJ; Peschar M; de Boer TP; Tidwell RR; Rook MB; Vos MA; van der Heyden MA
    Cardiovasc Res; 2013 Jul; 99(1):203-14. PubMed ID: 23625347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol blocks cardiac KATP and KG but not IK1 channels by acting at the bundle-crossing regions.
    Kikuta J; Ishii M; Kishimoto K; Kurachi Y
    Eur J Pharmacol; 2006 Jan; 529(1-3):47-54. PubMed ID: 16325804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voltage-dependent gating and block by internal spermine of the murine inwardly rectifying K+ channel, Kir2.1.
    Matsuda H; Oishi K; Omori K
    J Physiol; 2003 Apr; 548(Pt 2):361-71. PubMed ID: 12640008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for sequential ion-binding loci along the inner pore of the IRK1 inward-rectifier K+ channel.
    Shin HG; Xu Y; Lu Z
    J Gen Physiol; 2005 Aug; 126(2):123-35. PubMed ID: 16043774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-ion distributions in the cytoplasmic domain of inward rectifier potassium channels.
    Robertson JL; Palmer LG; Roux B
    Biophys J; 2012 Aug; 103(3):434-443. PubMed ID: 22947859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes.
    Kucheryavykh YV; Kucheryavykh LY; Nichols CG; Maldonado HM; Baksi K; Reichenbach A; Skatchkov SN; Eaton MJ
    Glia; 2007 Feb; 55(3):274-81. PubMed ID: 17091490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.
    López-Izquierdo A; Aréchiga-Figueroa IA; Moreno-Galindo EG; Ponce-Balbuena D; Rodríguez-Martínez M; Ferrer-Villada T; Rodríguez-Menchaca AA; van der Heyden MA; Sánchez-Chapula JA
    Pflugers Arch; 2011 Oct; 462(4):505-17. PubMed ID: 21779761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of fluorescence-based and automated patch clamp-based functional assays for the inward rectifier potassium channel Kir4.1.
    Raphemot R; Kadakia RJ; Olsen ML; Banerjee S; Days E; Smith SS; Weaver CD; Denton JS
    Assay Drug Dev Technol; 2013; 11(9-10):532-43. PubMed ID: 24266659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pore Polarity and Charge Determine Differential Block of Kir1.1 and Kir7.1 Potassium Channels by Small-Molecule Inhibitor VU590.
    Kharade SV; Sheehan JH; Figueroa EE; Meiler J; Denton JS
    Mol Pharmacol; 2017 Sep; 92(3):338-346. PubMed ID: 28619748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets.
    Noujaim SF; Stuckey JA; Ponce-Balbuena D; Ferrer-Villada T; López-Izquierdo A; Pandit S; Calvo CJ; Grzeda KR; Berenfeld O; Chapula JA; Jalife J
    FASEB J; 2010 Nov; 24(11):4302-12. PubMed ID: 20585026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.
    Pegan S; Arrabit C; Zhou W; Kwiatkowski W; Collins A; Slesinger PA; Choe S
    Nat Neurosci; 2005 Mar; 8(3):279-87. PubMed ID: 15723059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule.
    Takemoto Y; Slough DP; Meinke G; Katnik C; Graziano ZA; Chidipi B; Reiser M; Alhadidy MM; Ramirez R; Salvador-Montañés O; Ennis S; Guerrero-Serna G; Haburcak M; Diehl C; Cuevas J; Jalife J; Bohm A; Lin YS; Noujaim SF
    FASEB J; 2018 Apr; 32(4):1778-1793. PubMed ID: 29162702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inward rectification by polyamines in mouse Kir2.1 channels: synergy between blocking components.
    Xie LH; John SA; Weiss JN
    J Physiol; 2003 Jul; 550(Pt 1):67-82. PubMed ID: 12740427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ion-blocking sites of the Kir2.1 channel revealed by multiscale modeling.
    Tai K; Stansfeld PJ; Sansom MS
    Biochemistry; 2009 Sep; 48(36):8758-63. PubMed ID: 19653656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chloroquine inhibits tumor-related Kv10.1 channel and decreases migration of MDA-MB-231 breast cancer cells in vitro.
    Valdés-Abadía B; Morán-Zendejas R; Rangel-Flores JM; Rodríguez-Menchaca AA
    Eur J Pharmacol; 2019 Jul; 855():262-266. PubMed ID: 31082369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors.
    Ohno Y; Hibino H; Lossin C; Inanobe A; Kurachi Y
    Brain Res; 2007 Oct; 1178():44-51. PubMed ID: 17920044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels.
    McClenahan SJ; Kent CN; Kharade SV; Isaeva E; Williams JC; Han C; Terker A; Gresham R; Lazarenko RM; Days EL; Romaine IM; Bauer JA; Boutaud O; Sulikowski GA; Harris R; Weaver CD; Staruschenko A; Lindsley CW; Denton JS
    Mol Pharmacol; 2022 May; 101(5):357-370. PubMed ID: 35246480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synergistic blocking effect of Mg²⁺ and spermine on the inward rectifier K⁺ (Kir2.1) channel pore.
    Huang CW; Kuo CC
    Sci Rep; 2016 Feb; 6():21493. PubMed ID: 26869275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
    Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.
    Kojima A; Fukushima Y; Ito Y; Ding WG; Ueda R; Seto T; Kitagawa H; Matsuura H
    J Cardiovasc Pharmacol; 2018 Jan; 71(1):10-18. PubMed ID: 29283926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.